节点文献

氨甲环酸在创伤救治中的应用现状与展望

The application status and prospect of tranexamic acid in trauma management

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 罗小敏杨卫泽

【Author】 Luo Xiaomin;Yang Weize;Department of Emergency Medicine,Eastern Campus,Renmin Hospital of Wuhan University;

【通讯作者】 杨卫泽;

【机构】 武汉大学人民医院东院急诊科

【摘要】 创伤性凝血病和过度炎症导致的多器官功能障碍综合征是严重创伤危及患者生命的重要因素。氨甲环酸(TXA)是一种人工合成抗纤溶药物,兼具抗纤溶、抗炎、免疫调节及减轻血管内皮损伤等多重作用。TXA给药方式灵活,除静脉途径外,还可以口服、创伤局部使用或肌肉注射。多部国内外专家共识或指南均建议创伤后3h内应用TXA以降低创伤出血所致的病死率,推荐用法为:10min内给予1g负荷量静脉输注,随后8h给予1g维持量。时间窗内使用TXA是创伤救治策略的重要一环。

【Abstract】 Traumatic coagulopathy and multiple organ dysfunction syndrome caused by excessive inflammation are vital threats to the lives of patients with severe trauma.Besides the anti-fibrinolytic effect,tranexamic acid(TXA) has multiple beneficial effects in trauma cases,including anti-inflammation,immunomodulation and alleviating endothelial injury.TXA can be administered flexibly.In addition to intravenous infusion,TXA can also be administered orally,in wound area or by intramuscular injection.Some expert consensus or guidelines suggest the application of TXA within 3 hours after trauma to reduce the mortality caused by bleeding.The recommendation is that TXA be administered at a loading dose of 1 g infused intravenously over 10 minutes,followed by an infusion of 1 g over 8 hours.The application of TXA in the time window should be an essential component of cluster strategy for trauma management.

【关键词】 创伤出血氨甲环酸抗纤溶剂
【Key words】 traumableedingtranexamic acidanti-fibrinolytic drug
  • 【文献出处】 创伤外科杂志 ,Journal of Traumatic Surgery , 编辑部邮箱 ,2021年12期
  • 【分类号】R641
  • 【被引频次】1
  • 【下载频次】241
节点文献中: 

本文链接的文献网络图示:

本文的引文网络